Star Bulk Carriers Corp vs Vir Biotechnology Inc. Common Stock — how do they compare? Star Bulk Carriers Corp trades at $28.34 (market cap $3.34B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Star Bulk Carriers Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.53% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Star Bulk Carriers Corp for 23 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SBLK | VIR | |
|---|---|---|
Market Cap | $3.34B | $1.76B |
Volume | 1,935,552 | 2,764,948 |
Sector | Industrials | Health |
52-Week High | $32.49 | $11.78 |
52-Week Low | $17.42 | $5.12 |
Typical Hold Time | 23 Days | 0 Days |
Enterprise Value | $4.02B | $1.32B |
Dividend Yield | 6.53% | — |
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $29.79, down 0.17% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company demonstrates strong fundamental performance, with Q2 2026 EPS of $1.21 beating expectations and a 23.87% net income margin. Recent news highlights insider buying and a declared $0.90 dividend, reflecting management confidence and shareholder returns.
SBLK presents a compelling value case with a P/E of 11.28 and robust profitability, though near-term technical weakness and shipping market volatility pose risks. Analyst consensus is bullish with 14 buy ratings, supporting upside potential if earnings momentum continues into Q3.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →